Showing results (1001-1010 of 1,571) with videos related to
Sort By:
Pageof 158
Nutrients|April 27, 2017
Sweet Taste Receptor Activation in the Gut Is of Limited Importance for Glucose-Stimulated GLP-1 and GIP SecretionMonika Y Saltiel, Rune E Kuhre, Charlotte B Christiansen, et al.Diabetes|February 19, 2011
GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetesNikolaos Mentis, Irfan Vardarli, Lars D Köthe, et al.Neurogastroenterology and Motility|June 30, 2010
Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasisT Edholm, M Degerblad, P Grybäck, et al.HIV Medicine|April 6, 2005
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapyO Andersen, S B Haugaard, J J Holst, et al.Endocrine Connections|January 18, 2015
Stability of glucagon-like peptide 1 and glucagon in human plasmaNicolai J Wewer Albrechtsen, Monika J Bak, Bolette Hartmann, et al.The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantationE Christiansen, A Tibell, A Vølund, et al.Diabetologia|October 30, 1998
Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cellsK Almind, L Ambye, S A Urhammer, et al.The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humansKirsten Vollmer, Husai Gardiwal, Bjoern A Menge, et al.Metabolism: Clinical and Experimental|October 23, 2009
Effects of meal size and composition on incretin, alpha-cell, and beta-cell responsesJosina M Rijkelijkhuizen, Kelly McQuarrie, Cynthia J Girman, et al.Physiological Reports|September 28, 2016
Serum lipase activity and concentration during intravenous infusions of GLP-1 and PYY3-36 and after ad libitum meal ingestion in overweight menJulie B Schmidt, Anders Sjödin, Lene S Stevner, et al.Pageof 158